Cancer care is becoming more targeted with the development of therapies that address specific genetic signatures. Before such drugs are used, a test identifies whether a patient’s cancer matches an ...
A sleek and functional electric city commuter. Clean lines, aerodynamic design. Loads of accessories. Powerful pedal assistance up to 28 mph. Display can be hard to see in bright sun. You’ll feel the ...
Rehan Verjee is no stranger to making medicines, having taken several candidates through FDA approvals as the former president of EMD Serono and global head of the Innovative Medicine Franchises at ...
Using just 1mL of plasma, the Precede Bio platform identified key molecular pathways linked to response and resistance in patients with metastatic breast and prostate cancer treated with sacituzumab ...
BURLINGTON, Mass., Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative ...
A new spinout from Dana-Farber Cancer Institute aims to deliver a series of blood tests aimed not only at directing patients to precision tumor treatments, but also at assisting drug developers in ...
The Canyon Precede:ON seems every inch the concept bike made real. The winner of the 2021 German Design Award certainly looks the part, and it boasts a commitment to integration with no external ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback